Royal Bank of Canada’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28M | Buy |
93,396
+90,251
| +2,870% | +$1.24M | ﹤0.01% | 3381 |
|
|
2025
Q1 | $35K | Sell |
3,145
-600
| -16% | -$6.68K | ﹤0.01% | 5329 |
|
|
2024
Q4 | $40K | Sell |
3,745
-2,379
| -39% | -$25.4K | ﹤0.01% | 5309 |
|
|
2024
Q3 | $79K | Buy |
6,124
+863
| +16% | +$11.1K | ﹤0.01% | 5035 |
|
|
2024
Q2 | $88K | Sell |
5,261
-6,364
| -55% | -$106K | ﹤0.01% | 4961 |
|
|
2024
Q1 | $174K | Sell |
11,625
-8,998
| -44% | -$135K | ﹤0.01% | 4380 |
|
|
2023
Q4 | $309K | Buy |
20,623
+3,607
| +21% | +$54K | ﹤0.01% | 4196 |
|
|
2023
Q3 | $239K | Buy |
17,016
+764
| +5% | +$10.7K | ﹤0.01% | 4169 |
|
|
2023
Q2 | $168K | Buy |
16,252
+426
| +3% | +$4.4K | ﹤0.01% | 4485 |
|
|
2023
Q1 | $147K | Buy |
15,826
+939
| +6% | +$8.72K | ﹤0.01% | 4501 |
|
|
2022
Q4 | $132K | Buy |
14,887
+5
| +0% | +$44 | ﹤0.01% | 4786 |
|
|
2022
Q3 | $124K | Hold |
14,882
| – | – | ﹤0.01% | 4692 |
|
|
2022
Q2 | $122K | Sell |
14,882
-1,198
| -7% | -$9.82K | ﹤0.01% | 4744 |
|
|
2022
Q1 | $139K | Sell |
16,080
-1,646
| -9% | -$14.2K | ﹤0.01% | 4928 |
|
|
2021
Q4 | $168K | Sell |
17,726
-1,000
| -5% | -$9.48K | ﹤0.01% | 4988 |
|
|
2021
Q3 | $315K | Buy |
18,726
+298
| +2% | +$5.01K | ﹤0.01% | 4250 |
|
|
2021
Q2 | $281K | Sell |
18,428
-84,787
| -82% | -$1.29M | ﹤0.01% | 4313 |
|
|
2021
Q1 | $2.01M | Buy |
103,215
+6,311
| +7% | +$123K | ﹤0.01% | 2630 |
|
|
2020
Q4 | $1.75M | Sell |
96,904
-5,215
| -5% | -$94K | ﹤0.01% | 2626 |
|
|
2020
Q3 | $1.97M | Sell |
102,119
-78
| -0.1% | -$1.51K | ﹤0.01% | 2346 |
|
|
2020
Q2 | $2.67M | Buy |
102,197
+1,384
| +1% | +$36.1K | ﹤0.01% | 2097 |
|
|
2020
Q1 | $1.8M | Sell |
100,813
-1,330
| -1% | -$23.7K | ﹤0.01% | 2224 |
|
|
2019
Q4 | $3.41M | Buy |
102,143
+82,532
| +421% | +$2.75M | ﹤0.01% | 2046 |
|
|
2019
Q3 | $467K | Buy |
19,611
+1,672
| +9% | +$39.8K | ﹤0.01% | 3352 |
|
|
2019
Q2 | $645K | Buy |
17,939
+5,881
| +49% | +$211K | ﹤0.01% | 3177 |
|
|
2019
Q1 | $444K | Buy |
12,058
+5,495
| +84% | +$202K | ﹤0.01% | 3300 |
|
|
2018
Q4 | $283K | Sell |
6,563
-920
| -12% | -$39.7K | ﹤0.01% | 3532 |
|
|
2018
Q3 | $354K | Buy |
7,483
+1,427
| +24% | +$67.5K | ﹤0.01% | 3552 |
|
|
2018
Q2 | $301K | Buy |
6,056
+1,004
| +20% | +$49.9K | ﹤0.01% | 3611 |
|
|
2018
Q1 | $251K | Buy |
5,052
+1,297
| +35% | +$64.4K | ﹤0.01% | 3600 |
|
|
2017
Q4 | $140K | Buy |
3,755
+2,005
| +115% | +$74.8K | ﹤0.01% | 3907 |
|
|
2017
Q3 | $55K | Buy |
+1,750
| New | +$55K | ﹤0.01% | 4627 |
|